FBLN3 Antikörper (Middle Region)
Kurzübersicht für FBLN3 Antikörper (Middle Region) (ABIN630948)
Target
Alle FBLN3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- EFEMP1 antibody was raised against the middle region of EFEMP1
-
Aufreinigung
- Affinity purified
-
Immunogen
- EFEMP1 antibody was raised using the middle region of EFEMP1 corresponding to a region with amino acids NENGEFYLRQTSPVSAMLVLVKSLSGPREHIVDLEMLTVSSIGTFRTSSV
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
EFEMP1 Blocking Peptide, (ABIN5613311), is also available for use as a blocking control in assays to test for specificity of this EFEMP1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EFEMP1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- FBLN3 (Fibulin 3 (FBLN3))
-
Andere Bezeichnung
- EFEMP1
-
Hintergrund
- EFEMP1 genepans approximately 18 kb of genomic DNA and consists of 12 exons. Alternative splice patterns in the 5' UTR result in three transcript variants encoding the same extracellular matrix protein. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy.
-
Molekulargewicht
- 53 kDa (MW of target protein)
-
Pathways
- EGFR Signaling Pathway
Target
-